KRAS and colorectal cancer: Shows that in colorectal cancer: 1) mutant APC regulates extracellular vesicle (EV) secretion, while mutant TGFBR2 modulates EV composition; EV-mediated transfer of mutant KRAS and TP53 drives functional impacts on tumor progression.